PLEASANTON, Calif., Oct. 29, 2020 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced U.S. Food and Drug Administration (FDA) approval of expanded claims for the cobas® EGFR Mutation ...
HILDEN, Germany, and TOKYO--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the Japanese Pharmaceuticals and Medical Device Agency (PMDA) has approved the ...
MISSION HILLS, LOS ANGELES (KABC) -- A medical test for kidney function that adjusts its results for race is coming under increased scrutiny. Experts are saying the results for African-American ...
A race-specific algorithm designed to assess kidney function for individuals awaiting transplants jeopardized critical treatment for some Black Americans. An exclusive report by the Associated Press ...
In recent years, the medical community, researchers, and health policy makers have increasingly recognized that many long-established and widely used clinical decision-making tools actually perpetuate ...
CHICAGO -- There is new hope for thousands of African Americans waiting for a new kidney. A test to determine placement on a transplant waiting list has been deemed flawed. The finding will have a ...
- Lung cancer causes more than 1.7 million deaths worldwide each year, with NSCLC accounting for about 85 percent of all cases[1] - The cobas EGFR Mutation Test v2 is FDA approved as a companion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback